ARCHIVES

FDA Approves Avastin For Recurrent NSCLC

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

March 29, 2013

In Brief: Robert Miller To Head International Affairs Office’ Pitot: No Basis for 20% Estimate

December 1, 1978

In Brief: Henney To Leave NCI For Kansas; Dan Longo Heads BRMP; DeVita To Receive Nervi Award

May 10, 1985

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004